Enara Bio has snagged $32.5 million in a Series B fundraise, backed in part by Pfizer’s venture arm, to help develop a ...

Kurma Partners has closed the first part of its latest biotech-focused fund, following a pair of M&A exits for drug developers backed by its third fund. The Paris-based investment firm closed on the ...

A Louisiana judge on Monday defended a new state law that keeps drugmakers from imposing certain restrictions around the ...

Teladoc's chief operating officer has resigned due to an executive reshuffle, a few months after the company named a new CEO.

The Centers for Medicare & Medicaid Services wants earlier and more flexible communication with drugmakers during the next ...

BioNTech became a big name in biopharma thanks to its Pfizer-partnered Covid-19 vaccine. It's betting that artificial ...

Septerna is joining biotech's IPO on-deck circle, preparing for a public offering with two other startups that have recently ...

Gilead announced Wednesday that it will allow certain drug manufacturers to make and sell a generic version of its ...

Frazier Life Sciences has added more than $630 million to its evergreen public fund, the firm said Wednesday. The long-only ...

After an already brutal year for its Medicare Advantage business, major health insurer Humana said it’s taken a hit to its ...

Connie Health, a startup that matches seniors to Medicare plans, bought Redesign Health-backed competitor Keen Insurance ...

Wave Life Sciences brought in $230 million through an upsized public offering, extending its cash runway into 2027 as a ...